Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories

Journal of Clinical Microbiology

Volumn 50, Issue 12, 2012, Pages 4054-4060

  Domingo, Cristina ^a   Patel, Pranav ^a   Yillah, Jasmin ^a   Weidmann, Manfred ^b   Méndez, Jairo A ^c   Nakouné, Emmanuel Rivalyn ^d   Niedrig, Matthias ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c INSTITUTO NACIONAL DE SALUD   (Colombia)

^d INSTITUT PASTEUR DE BANGUI   (Central African Republic)

Author keywords

[No Author keywords available]

Indexed keywords

HELICASE;

ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; GENE AMPLIFICATION; GENOME ANALYSIS; HEALTH CARE FACILITY; HUMAN; LIMIT OF DETECTION; MOLECULAR DIAGNOSIS; MOLECULAR PROBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SUPERNATANT; VERO CELL; VIRUS CULTURE; VIRUS GENOME; VIRUS STRAIN; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS;

CLINICAL LABORATORY TECHNIQUES; GENOME, VIRAL; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POINT-OF-CARE SYSTEMS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIROLOGY; YELLOW FEVER; YELLOW FEVER VIRUS;

YELLOW FEVER VIRUS;

EID: 84869236290     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01799-12     Document Type: Article

References (23)

1. Amarasinghe A, Kuritsk JN, Letson GW, Margolis HS. 2011. Dengue virus infection in Africa. Emerg. Infect. Dis. 17:1349-1354.
2. Bae HG, Nitsche A, Teichmann A, Biel SS, Niedrig M. 2003. Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay. J. Virol. Methods 110:185-191. (Pubitemid 36645263)
3. Bae HG, et al. 2005. Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium. J. Clin. Virol. 33:274-280.
4. Barban V, et al. 2007. High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production. Vaccine 25:2941-2950. (Pubitemid 46420609)
5. Craw P, Balachandran W. 2012. Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review. Lab Chip 12:2469-2486.
6. Domingo C, Patel P, Linke S, Achazi K, and Niedrig M. 2011. Molecular diagnosis of flaviviruses. Future Virol. 6:1059-1074.
7. Domingo C, et al. 2011. Detection of yellow fever 17D genome in urine. J. Clin. Microbiol. 49:760-762.
8. Domingo C, et al. 2012. First international external quality assessment study on molecular and serological methods for yellow fever diagnosis. PLoS One 7:e36291. doi:10.1371/journal.pone.0036291.
9. Gardner CL, Ryman KD. 2010. Yellow fever: a reemerging threat. Clin. Lab. Med. 30:237-260.
10. Gershman MD, et al. 2012. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 30:5038-5058.
11. Heraud JM, et al. 1999. First case of yellow fever in French Guiana since 1902. Emerg. Infect. Dis. 5:429-432. (Pubitemid 29289457)
12. Houghton-Triviño N, Montaña D, Castellanos J. 2008. Dengue-yellow fever sera cross-reactivity; challenges for diagnosis. Rev. Salud Publica (Bogotá) 10:299-307.
13. Kim HJ, et al. 2011. A rapid and simple isothermal nucleic acid amplification test for detection of herpes simplex virus types 1 and 2. J. Clin. Virol. 50:26-30.
14. Macnamara FN. 1957. A clinico-pathological study of yellow fever in Nigeria. W. Afr. Med. J. 6:137-146.
15. Nunes MR, et al. 2011. Evaluation of two molecular methods for the detection of yellow fever virus genome. J. Virol. Methods 174:29-34.
16. Pan American Health Organization (PAHO). 2005. Control of yellow fever: field guide. PAHO scientific and technical publication no. 603. Pan American Health Organization, Washington, DC. http://www.paho.org/english/ad/fch/im/ fieldguide-yellowfever.pdf.
17. Posthuma-Trumpie GA, Korf J, van Amerongen A. 2009. Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey. Anal. Bioanal. Chem. 393:569-582. (Pubitemid 50238446)
18. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599. (Pubitemid 47236692)
19. Teichmann D, et al. 1999. A haemorrhagic fever from the Cote d'Ivoire. Lancet 354:1608. (Pubitemid 29515954)
20. Vainio J, Cutts F. 1998. Yellow fever. Division of Emerging and Other Communicable Diseases Surveillance and Control, WHO, Geneva, Switzerland.
21. Vincent M, Xu Y, Kong H. 2004. Helicase-dependent isothermal DNA amplification. EMBO Rep. 5:795-800. (Pubitemid 39199169)
22. Weidmann M, et al. 2010. Improved LNA probe-based assay for the detection of African and South American yellow fever virus strains. J. Clin. Virol. 48:187-192.
23. World Health Organization. 2010. Yellow fever fact sheet. Wkly. Epidemiol. Rec. 85:33-36.